StockWatch
·
Pharmaceuticals
Quarterly Updates15 May 2026, 07:01 pm

Accretion Nutraveda H2 FY26 Revenue Up 80.09% YoY

AI Summary

Accretion Nutraveda Limited (BSE SME: ANL) reported strong financial results for H2 FY26 and FY26. H2 FY26 revenue increased by 80.09% YoY to ₹19.54 crore, and EBITDA grew by 42.64% YoY to ₹3.68 crore. FY26 revenue rose by 110.00% YoY to ₹33.60 crore, with EBITDA up 87.94% YoY to ₹7.01 crore. The company's Managing Director, Mr. Mayur Popatlal Sojitra, highlighted the successful IPO and listing on the BSE SME Platform, which will support future expansion plans.

Key Highlights

  • H2 FY26 revenue increased by 80.09% YoY to ₹19.54 crore.
  • H2 FY26 EBITDA grew by 42.64% YoY to ₹3.68 crore.
  • FY26 revenue rose by 110.00% YoY to ₹33.60 crore.
  • FY26 EBITDA increased by 87.94% YoY to ₹7.01 crore.
  • PAT for FY26 increased by 102.80% YoY to ₹5.07 crore.